SOLVING KIDS' CANCER'S

RESEARCH PORTFOLIO 

SKC prioritizes and funds innovative preclinical research and early phase clinical trials with strong rationale for potential benefit to children with poor-prognosis cancers. The SKC approach involves collaborating with key stakeholders including scientists, clinicians, regulatory experts, and industry representatives to accelerate impactful advances globally. The mission-driven work of SKC has been carried out in over 110 cancer centers across 15 countries to date. Funded projects include 14 international studies and represent collaborations with 20 different charity partners.

2018 - 2021

2016 - 2017

2014 - 2015

2012 - 2013

2010 - 2011

2008 - 2009